3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
6
Neoplasms
4
Multiple Myeloma
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Sarcoma
2
Radiation Injuries
2
Osteosarcoma
2
Melanoma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Head and Neck Neoplasms
2
Cognitive Dysfunction
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Thoracic Neoplasms
1
Testicular Neoplasms
1
Substance-Related Disorders
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Interventions
Temozolomide
12
Magnetic Resonance Spectroscopy
9
Radiotherapy
6
Surveys and Questionnaires
5
Blood Specimen Collection
4
Transurethral Resection of Bladder
3
Surgical Procedures, Operative
3
Radiation
3
Perfusion Magnetic Resonance Imaging
2
Magnetic Resonance Imaging
2
Lomustine
2
Immunotherapy
2
Drug Therapy
2
Chemoradiotherapy
2
Amplified Fragment Length Polymorphism Analysis
2
regorafenib
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
gadodiamide
1
apatinib
1
Ultrasonography
1
Trail Making Test
1
Therapies, Investigational
1
Tablets
1
Standard of Care
1
Specimen Handling
1
Sampling Studies
1
Re-Irradiation
1
Quality of Life
1
Psychometrics
1
Proton Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Glioblastoma
×
Patient Reported Outcome Measures
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled